STORY: Tesla CEO Elon Musk’s neurotechnology company Neuralink plans to begin human clinical trials of its wireless brain computer chips in an estimated six months. Musk said during a presentation of the implant on Wednesday, “We’re extremely cautious and want to make sure it works well before we put a device in a human, but we’ve I think we’ve filed most of our paperwork with the FDA.” Musk wants to use the interfaces to heal neurological diseases such as Alzheimer’s, dementia and spinal cord injuries. Based in Austin, Texas, the company has successfully conducted clinical trials on animals over the past few years. Musk showed video footage of a monkey who is said to have operated a virtual keyboard using only the power of his mind. Nevertheless, the company is well behind its announced schedule.